Analysis of the TCGA dataset, using the UALCAN analysis platform [25], also revealed a significant downregulation of ITM2A gene transcripts in human prostate adenocarcinoma patients compared to control subjects (Figure 6F). The gene discussed is ITM2A; the disease is prostate adenocarcinoma.